phase readout
saveNCT05210413: Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: University Hospital, Bordeaux. Phase: PHASE1. Conditions: Refractory or Recurrent Solid Tumor
view source ↗
comments(0)
5-min edit window · permanent after that